diapason glp-1 Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products 2 Pack GLP-1, GLP-1 Oral

Cancer statistics, 2025

FDA has specifically flagged concerns with compounded injectable GLP-1 products, including: Nausea, vomiting, diarrhea, abdominal pain, and constipation Excessive dosing tied to titration mistakes, some serious enough to require hospitalization Concentration, measurement, labeling, and dosing considerations a mass-manufactured branded pen doesn't have in the same way A licensed provider needs to review your full medical history, current medications, and complete medication-specific risk information with you before treatment starts - this section is a prompt to have that conversation, not a substitute for it

When food stays in your stomach longer, you feel full longer

If you experience dizziness, confusion, shakiness, or lightheadedness especially if youre taking medications that lower blood sugarthese symptoms should not be ignored and should be assessed by a clinician

Patients should verify the pharmacys credibility and consult a healthcare provider before considering this option

To ensure that people do not take GLP-1 drugs without a medical prescription and to curb malpractices, the Drug Controller General of India, in collaboration with State Drug Controllers, took the following actions: On 10th March 2026, a comprehensive advisory was issued to all drug manufacturers to stop misleading advertisements and any promotion that could encourage people to use GLP-1 drugs without a prescription